InterVenn

South San Francisco, United States

InterVenn unlocks the glycoproteome using artificial intelligence for the development of transformational healthcare solutions in DX and Rx.

Aug 2021

Series C

Top Investors

Amplify PartnersTrue VenturesSoftBank GroupAnzu PartnersGenoa Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are InterVenn's investors?

InterVenn's investors include Amplify Partners, True Ventures, SoftBank Group, Anzu Partners, Genoa Ventures.

Where is InterVenn headquartered?

InterVenn is headquartered in South San Francisco, United States.

What does InterVenn do?

InterVenn unlocks the glycoproteome using artificial intelligence for the development of transformational healthcare solutions in DX and Rx.

What stage is InterVenn at?

InterVenn is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 2, 2021.

MLA

"InterVenn — Funding & Investors." VCBacked, August 2, 2021, https://www.vcbacked.co/company/intervenn. Accessed July 1, 2026.

APA

VCBacked. (2021). InterVenn — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/intervenn

Wikipedia (cite web)

{{cite web |title=InterVenn — Funding & Investors |url=https://www.vcbacked.co/company/intervenn |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 2, 2021.